Skip to results
Modify your search
NARROW
1-20 of 94
Authors: Judith S Currier
Journal Article
EDITOR'S CHOICE
Factors Affecting Risk of Cardiovascular Disease (CVD) Events in a Global CVD Prevention Cohort of People With Human Immunodeficiency Virus (HIV) Open Access
Clinical Infectious Diseases, ciaf210, https://doi.org/10.1093/cid/ciaf210
Published: 25 April 2025
Journal Article
EDITOR'S CHOICE
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort Open Access
Open Forum Infectious Diseases, Volume 12, Issue 4, April 2025, ofaf177, https://doi.org/10.1093/ofid/ofaf177
Published: 21 March 2025
Journal Article
Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR, Phase 3, Randomized, Double-blind, Placebo-Controlled Trial Open Access
Clinical Infectious Diseases, ciaf029, https://doi.org/10.1093/cid/ciaf029
Published: 17 February 2025
Journal Article
Viral and Symptom Rebound Following Anti–Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial Get access
The Journal of Infectious Diseases, Volume 231, Issue 1, 15 January 2025, Pages 131–136, https://doi.org/10.1093/infdis/jiae501
Published: 14 October 2024
Journal Article
Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV Open Access
Open Forum Infectious Diseases, Volume 11, Issue 10, October 2024, ofae574, https://doi.org/10.1093/ofid/ofae574
Published: 10 October 2024
Journal Article
SARS-CoV-2 Monoclonal Antibody Treatment Followed by Vaccination Shifts Human Memory B-Cell Epitope Recognition, Suggesting Antibody Feedback Free
The Journal of Infectious Diseases, Volume 230, Issue 5, 15 November 2024, Pages 1187–1196, https://doi.org/10.1093/infdis/jiae371
Published: 22 July 2024
Journal Article
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial Free
The Journal of Infectious Diseases, Volume 230, Issue 5, 15 November 2024, Pages 1177–1186, https://doi.org/10.1093/infdis/jiae369
Published: 20 July 2024
Journal Article
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19 Get access
Clinical Infectious Diseases, Volume 79, Issue 4, 15 October 2024, Pages 920–927, https://doi.org/10.1093/cid/ciae324
Published: 17 July 2024
Journal Article
Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Free
The Journal of Infectious Diseases, Volume 230, Issue 2, 15 August 2024, Pages 394–402, https://doi.org/10.1093/infdis/jiae192
Published: 08 May 2024
Journal Article
Response to Drs de Grooth and Parienti Free
The Journal of Infectious Diseases, Volume 229, Issue 5, 15 May 2024, Page 1596, https://doi.org/10.1093/infdis/jiae053
Published: 07 February 2024
Journal Article
Weight Changes and Adverse Pregnancy Outcomes With Dolutegravir- and Tenofovir Alafenamide Fumarate–Containing Antiretroviral Treatment Regimens During Pregnancy and Postpartum Free
Clinical Infectious Diseases, Volume 78, Issue 6, 15 June 2024, Pages 1617–1628, https://doi.org/10.1093/cid/ciae001
Published: 05 January 2024
Journal Article
401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy Open Access
Open Forum Infectious Diseases, Volume 10, Issue Supplement_2, December 2023, ofad500.471, https://doi.org/10.1093/ofid/ofad500.471
Published: 27 November 2023
Journal Article
Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus Open Access
Open Forum Infectious Diseases, Volume 10, Issue 10, October 2023, ofad467, https://doi.org/10.1093/ofid/ofad467
Published: 08 September 2023
Journal Article
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19 Free
The Journal of Infectious Diseases, Volume 228, Issue Supplement_2, 1 September 2023, Pages S117–S125, https://doi.org/10.1093/infdis/jiad287
Published: 31 August 2023
Journal Article
Variant-Specific Viral Kinetics in Acute COVID-19 Free
The Journal of Infectious Diseases, Volume 228, Issue Supplement_2, 1 September 2023, Pages S136–S143, https://doi.org/10.1093/infdis/jiad314
Published: 31 August 2023
Journal Article
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial Free
The Journal of Infectious Diseases, Volume 228, Issue Supplement_2, 1 September 2023, Pages S92–S100, https://doi.org/10.1093/infdis/jiad209
Published: 31 August 2023
Journal Article
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients Free
The Journal of Infectious Diseases, Volume 228, Issue Supplement_2, 1 September 2023, Pages S77–S82, https://doi.org/10.1093/infdis/jiad246
Published: 31 August 2023
Journal Article
Immune Status and SARS-CoV-2 Viral Dynamics Free
The Journal of Infectious Diseases, Volume 228, Issue Supplement_2, 1 September 2023, Pages S111–S116, https://doi.org/10.1093/infdis/jiad200
Published: 31 August 2023
Journal Article
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial Free
The Journal of Infectious Diseases, Volume 228, Issue Supplement_2, 1 September 2023, Pages S83–S91, https://doi.org/10.1093/infdis/jiad300
Published: 31 August 2023
Journal Article
Long COVID After Bamlanivimab Treatment Free
The Journal of Infectious Diseases, Volume 228, Issue Supplement_2, 1 September 2023, Pages S126–S135, https://doi.org/10.1093/infdis/jiad286
Published: 31 August 2023
